Avenue Therapeutics Inc.

NASDAQ: ATXI · Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM

Avenue Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.91M -1.6M -3.16M -2.82M -3.71M -2.12M -2.07M -3.92M -6.43M -3.91M -663K -605K -2.86M -914K -872K -951K -1M
Interest Income
32K 24K 51K 52K 49K 22K 9K 57K 37K 16K 1K 1K 2K 1K 1K 2K 3K
Pretax Income
-1.85M -1.56M -3.09M -2.7M -4.35M 617K 513K -4.02M -7.6M 524K -662K -604K -2.86M -913K -871K -949K -998K
Net Income
-1.85M -1.54M -3.08M -7.19M -4.34M 640K 526K -4.01M -7.54M 575K -662K -604K -2.86M -913K -871K -949K -998K
Selling & General & Admin
1.49M 1.03M 829K 1.46M 1.32M 1.14M 1.16M 896K 984K 3.37M 469K 454K 1.05M 524K 594K 623K 743K
Research & Development
411K 565K 2.33M 1.36M 2.39M 982K 907K 3.03M 5.45M 545K 194K 151K 1.81M 390K 278K 328K 258K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.91M 1.6M 3.16M 2.82M 3.71M 2.12M 2.07M 3.92M 6.43M 3.91M 663K 605K 2.86M 914K 872K 951K 1M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 332K 1.16M n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.91M 1.6M 3.16M 2.82M 3.71M 2.12M 2.07M 3.92M 6.43M 3.91M 663K 605K 2.86M 914K 872K 951K 1M
Income Tax Expense
n/a -9K n/a n/a 9K n/a -2.07K n/a n/a n/a -2K -1K -4K n/a n/a n/a n/a
Shares Outstanding (Basic)
2.97M 1.6M 1.6M 1.12M 562.04K 25.6M 8.11M 7.76M 5.57M 1.41M 1.47M 1.46M 1.4M 1.22M 1.11M 1.1M 1.1M
Shares Outstanding (Diluted)
2.97M 1.6M 1.6M 1.12M 562.04K 25.6M 8.11M 103.44K 5.57M 1.41M 1.47M 1.46M 1.4M 1.22M 1.11M 1.1M 1.1M
EPS (Basic)
-0.62 4.54 -1.92 -6.43 -7.72 0.03 4.86 -38.74 -101.57 3.57 -0.45 -0.41 -153.75 -0.75 -0.79 -0.86 -0.9
EPS (Diluted)
-0.62 4.54 -1.92 -6.43 -7.72 0.03 4.86 -38.74 -101.57 3.57 -0.45 -0.41 -153.75 -0.75 -0.79 -0.86 -0.9
EBITDA
-1.91M -1.56M -3.09M -2.7M -3.71M 2.74M 513K -3.87M -6.43M 5.6M -662K -604K -2.86M -914K -872K -951K -1M
EBIT
-1.91M -1.56M -3.09M -2.7M -4.35M 617K 513K -4.02M -7.27M 1.69M -662K -604K -2.86M -914K -872K -951K -1M
Depreciation & Amortization
n/a -3.9M 69K 122K 3.71M 2.12M 2.07M 3.92M 6.43M 3.91M 663K 605K 2.86M 914K 872K 951K 1M